- Plans to Develop High-Efficacy Skincare Products Through Strengthened Bio-peptide Research Collaboration

Amorepacific has signed a Memorandum of Understanding (MOU) with Caregen Co., Ltd. to strengthen bio-peptide research collaboration. The ceremony, conducted for technological cooperation concerning biomimetic peptides, was held on the 20th at Amorepacific's headquarters in Yongsan-gu, Seoul.

Caregen leads global peptide research and development and is a biotechnology company providing healthcare solutions across all sectors of the anti-aging industry. Caregen is developing bio-peptides optimized for human skin in terms of efficacy and safety through its biomimetic and hybrid peptide research approaches.

Through this agreement, Amorepacific intends to bolster its peptide research collaboration with Caregen and develop bio-cosmetics equipped with high-efficacy skincare solutions. Furthermore, the company aims to scientifically verify peptides, a prominent anti-aging ingredient, and enhance its competitiveness in the global skincare market through various research outcomes.

Seunghwan Kim, the CEO of Amorepacific Corp., stated, “This agreement signifies a meaningful collaboration where Amorepacific's high-efficacy skincare technology meets Caregen, a leader in peptide research, creating mutual synergy.” He added, “Amorepacific will continue to intensify our research on high-efficacy anti-aging products and spare no effort to develop innovative products to showcase to customers worldwide.”

Chung Yong-ji, the CEO of Caregen, expressed, “The 1,060 active peptides developed by Caregen over the past 22 years will be provided through research and commercialization collaboration in various dermatological fields with Amorepacific. Both companies can synergize towards our shared goal of enhancing human health and happiness."

Meanwhile, Amorepacific has launched high-efficacy anti-aging skincare products such as IOPE Retinol Expert and LANEIGE Perfect Renew, utilizing various peptide ingredients. Recently, the company has continued research on different types of bioactive peptides, including plant-derived peptides and recombinant peptides, using synthetic biology techniques, pushing forward innovative product development.